⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Navendra SinghM.D.

Internal Medicine · New York, NY 10065

NPI: 1033571500

Share:

36

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers90th percentile opioid prescribingHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

108

Total Claims

$4,199

Drug Cost

48

Beneficiaries

$87

Cost/Patient

Risk Score Breakdown 36/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8
Opioid rate (national percentile)+3

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+1885%

Opioid rate vs peers

44.4% vs 2.2% avg

-94%

Cost per patient vs peers

$87 vs $1,411 avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 1,885% above the average for Internal Medicine providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

44.4%

Opioid Rate

48

Opioid Claims

$1,965

Opioid Cost

41.7%

Long-Acting Rate

This provider's opioid prescribing rate of 44.4% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

100% generic

Brand: 0 claims · $0

Generic: 98 claims · $3,305

Patient Profile

73

Avg Age

50%

Female

4.00

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About